Infectious Disease Diagnostic Market worth $40.53 billion by 2030, growing at a CAGR of 7.29% - Exclusive Report by 360iResearch

The "Infectious Disease Diagnostic Market by Product (Instruments, Reagents, Software & Services), Technology (Biochemical Technology, Conventional Technology, Molecular Technology), Testing Type, Sample, Application, End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Infectious Disease Diagnostic Market to grow from USD 24.76 billion in 2023 to USD 40.53 billion by 2030, at a CAGR of 7.29%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/infectious-disease-diagnostic?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Infectious disease diagnostics products are designed to detect and identify pathogens that cause human infections. These diagnostics play a critical role in healthcare by facilitating the accurate and timely recognition of infectious agents, thus ensuring prompt and appropriate clinical management. The modalities for infectious disease diagnostics include culture techniques, molecular diagnostics, serology, antigen-based tests, and next-generation sequencing for guiding treatment decisions, monitoring disease outbreaks, and implementing infection control measures to prevent the spread of pathogens within communities and healthcare settings. In recent years, outbreaks of infectious diseases have resulted in an urgent need for reliable diagnostics. In addition, growth in healthcare spending and improvements in laboratory infrastructure globally contribute to the penetration of infectious disease diagnostic solutions. Moreover, government initiatives and regulatory approvals for innovative diagnostic solutions have expanded the availability of novel infectious disease diagnostic solutions. However, high costs associated with advanced diagnostic technologies could limit adoption in cost-sensitive regions. The lack of skilled professionals in emerging markets to operate sophisticated diagnostic equipment may restrict product penetration. Nevertheless, the integration of advanced technologies for enhanced data analysis and interpretation of complex diagnostic tests has enhanced the outputs of diagnostic tests. In addition, continuous development in diagnostic technologies, including rapid PCR systems and next-generation sequencing, drives the demand for infectious disease diagnostics products by offering quicker and more accurate results.

The infectious disease diagnostic market in the Americas is observing rapid growth due to the increasing prevalence of infectious diseases, advanced diagnostic technologies, and growing awareness of early disease detection. The adoption of advanced technologies, well-established healthcare infrastructure, and the presence of the majority of vendors contribute to the infectious disease diagnostic market in the Americas. European Union's (EU) regulations and a sophisticated healthcare system largely influence Europe's market. EU countries invest heavily in research and innovation, exemplified by initiatives to foster the development of advanced diagnostics and resonate with proactive customer behavior toward disease prevention and management. The Middle East market is directed by significant healthcare spending and the adoption of high-tech diagnostic equipment, particularly in Gulf Cooperation Council (GCC) countries. The need for accessible and affordable diagnostics to combat prevalent infectious diseases such as HIV/AIDS, tuberculosis, and malaria has improved the need for infectious disease diagnosis products in Africa. The infectious disease diagnostic market in the Asia-Pacific is expanding rapidly due to its large population and increased healthcare expenditure. The government's focus on healthcare reform and the rise of domestic companies contribute to the growth of infectious disease diagnostics.

Market Segmentation & Coverage:

This research report categorizes the Infectious Disease Diagnostic Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments, Reagents, and Software & Services. The Instruments is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Biochemical Technology, Conventional Technology, and Molecular Technology. The Molecular Technology is projected to witness significant market share during forecast period.

Based on Testing Type, market is studied across Laboratory Testing and PoC Testing. The PoC Testing is projected to witness significant market share during forecast period.

Based on Sample, market is studied across Blood, Plasma, & Serum and Urine. The Blood, Plasma, & Serum is projected to witness significant market share during forecast period.

Based on Application, market is studied across Bacterial Infection, Cardiovascular Infection, CNS Infection, Fungal Infection, Sexually Transmitted Disease, and Viral Infection. The Cardiovascular Infection is projected to witness significant market share during forecast period.

Based on End User, market is studied across Diagnostic Laboratories, Hospital, and Research Institutes. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.72% in 2023, followed by Asia-Pacific.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/infectious-disease-diagnostic?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Infectious Disease Diagnostic Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Infectious Disease Diagnostic Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Infectious Disease Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, bioMérieux SA, Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Grifols, S.A., Hologic Inc., Illumina, Inc., Johnson & Johnson Services, Inc., Konica Minolta, Inc., Labsystems Diagnostics Oy, Merck KGaA, Olympus Corporation, Perkin Elmer, Inc., Pfizer Inc., Qiagen N.V., Quest Diagnostics, Siemens Healthineers AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Infectious Disease Diagnostic Market, by Product
7. Infectious Disease Diagnostic Market, by Technology
8. Infectious Disease Diagnostic Market, by Testing Type
9. Infectious Disease Diagnostic Market, by Sample
10. Infectious Disease Diagnostic Market, by Application
11. Infectious Disease Diagnostic Market, by End User
12. Americas Infectious Disease Diagnostic Market
13. Asia-Pacific Infectious Disease Diagnostic Market
14. Europe, Middle East & Africa Infectious Disease Diagnostic Market
15. Competitive Landscape
16. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Infectious Disease Diagnostic Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Infectious Disease Diagnostic Market?
3. What is the competitive strategic window for opportunities in the Infectious Disease Diagnostic Market?
4. What are the technology trends and regulatory frameworks in the Infectious Disease Diagnostic Market?
5. What is the market share of the leading vendors in the Infectious Disease Diagnostic Market?
6. What modes and strategic moves are considered suitable for entering the Infectious Disease Diagnostic Market?

Read More @ https://www.360iresearch.com/library/intelligence/infectious-disease-diagnostic?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.